FDA approves Roche drug for rare autoimmune disorder NMOSD August 17, 2020 Auto Bot autoimmune disease, Basel, BioPharma, biopharma nl, Food and Drug Administration, Roche, Switzerland 0 The agency approved Enspryng for the disease, which is often misdiagnosed as multiple sclerosis and can cause blindness, muscle weakness and paralysis.